The analysis by Manuel and colleagues creates controversy with headlines, not data.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

Volumn 172, Issue 8, 2005, Pages

  Genest, Jacques ^a   McPherson, Ruth ^a   Frohlich, Jiri ^a   Fodor, George ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

BLOOD; CANADA; CORONARY ARTERY DISEASE; HEALTH CARE COST; HUMAN; HYPERLIPIDEMIA; MORTALITY; NOTE; PRACTICE GUIDELINE; RISK FACTOR;

ANTILIPEMIC AGENTS; CANADA; CHOLESTEROL, LDL; CORONARY DISEASE; HEALTH EXPENDITURES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; PRACTICE GUIDELINES; RISK FACTORS;

EID: 23044445879     PISSN: None     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.1041427     Document Type: Note

References (0)